Christopher P Kiritsy - Net Worth and Insider Trading
Christopher P Kiritsy Net Worth
The estimated net worth of Christopher P Kiritsy is at least $2,438 dollars as of 2024-05-28. Christopher P Kiritsy is the Director of Pieris Pharmaceuticals Inc and owns about 250 shares of Pieris Pharmaceuticals Inc (PIRS) stock worth over $2,438. Details can be seen in Christopher P Kiritsy's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Christopher P Kiritsy has not made any transactions after 2023-05-25 and currently still holds the listed stock(s).
Transaction Summary of Christopher P Kiritsy
Christopher P Kiritsy Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christopher P Kiritsy owns 2 companies in total, including Pieris Pharmaceuticals Inc (PIRS) , and HTG Molecular Diagnostics Inc (HTGMQ) .
Click here to see the complete history of Christopher P Kiritsy’s form 4 insider trades.
Insider Ownership Summary of Christopher P Kiritsy
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PIRS | Pieris Pharmaceuticals Inc | 2023-05-25 | director |
| HTGMQ | HTG Molecular Diagnostics Inc | 2022-01-27 | director |
Christopher P Kiritsy Latest Holdings Summary
Christopher P Kiritsy currently owns a total of 1 stock. Christopher P Kiritsy owns 250 shares of Pieris Pharmaceuticals Inc (PIRS) as of May 25, 2023, with a value of $2,438.
Latest Holdings of Christopher P Kiritsy
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PIRS | Pieris Pharmaceuticals Inc | 2023-05-25 | 250 | 9.75 | 2,438 |
Holding Weightings of Christopher P Kiritsy
Christopher P Kiritsy Form 4 Trading Tracker
According to the SEC Form 4 filings, Christopher P Kiritsy has made a total of 1 transactions in Pieris Pharmaceuticals Inc (PIRS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Pieris Pharmaceuticals Inc is the acquisition of 125 shares on May 25, 2023, which cost Christopher P Kiritsy around $8,500.
Insider Trading History of Christopher P Kiritsy
- 1
Christopher P Kiritsy Trading Performance
GuruFocus tracks the stock performance after each of Christopher P Kiritsy's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Christopher P Kiritsy is -50.68%. GuruFocus also compares Christopher P Kiritsy's trading performance to market benchmark return within the same time period. The performance of stocks bought by Christopher P Kiritsy within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Christopher P Kiritsy's insider trading performs compared to the benchmark.
Performance of Christopher P Kiritsy
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -34.34 | | | | | |
| Relative Return to S&P 500(%) | -34.34 | | | | | |
Christopher P Kiritsy Ownership Network
Christopher P Kiritsy Owned Company Details
What does Pieris Pharmaceuticals Inc do?
Who are the key executives at Pieris Pharmaceuticals Inc?
Christopher P Kiritsy is the director of Pieris Pharmaceuticals Inc. Other key executives at Pieris Pharmaceuticals Inc include 10 percent owner Bvf Gp Holdings Llc , other: See Explanation of Responses Bvf Ii Gp Llc , and 10 percent owner Bvf I Gp Llc .
Pieris Pharmaceuticals Inc (PIRS) Insider Trades Summary
Over the past 18 months, Christopher P Kiritsy made 1 insider transaction in Pieris Pharmaceuticals Inc (PIRS) with a net purchase of 10,000.
In summary, during the past 3 months, insiders sold 0 shares of Pieris Pharmaceuticals Inc (PIRS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Pieris Pharmaceuticals Inc (PIRS) were sold and 125 shares were bought by its insiders, resulting in a net purchase of 125 shares.
Pieris Pharmaceuticals Inc (PIRS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Pieris Pharmaceuticals Inc Insider Transactions
Christopher P Kiritsy Mailing Address
Above is the net worth, insider trading, and ownership report for Christopher P Kiritsy. Currently GuruFocus does not have mailing address information for Christopher P Kiritsy.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
